Clinical Trial Update: A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers. [Phase 1]

View source ↗

Summary

This is a Phase 1 clinical trial evaluating Eloralintide (LY3841136) in participants with varying levels of liver function, including healthy livers, with recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency

Drugs mentioned

• Eloralintide (LY3841136)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hepatic Insufficiency | Phase 1 | Status: RECRUITING